Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series - Archive ouverte HAL Access content directly
Journal Articles Journal of Clinical Apheresis Year : 2022

Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series

(1, 2) , (3, 2) , (4) , (2) , (5) , (5) , (6) , (1)
1
2
3
4
5
6

Abstract

Background Rheopheresis is a double-filtration plasmapheresis that removes high-molecular-weight molecules from the plasma and thereby lowers blood viscosity. This treatment has been proposed in hemodialysis (HD) patients for chronic limb-threatening ischemia (CLTI), but very few studies have evaluated the usefulness of this technique. Principal Objective To assess 1-year amputation-free survival (AFS) of HD patients suffering from CLTI treated by rheopheresis. Material and Method We conducted a retrospective study of 28 consecutive HD patients treated by rheopheresis in three French dialysis centers between 1 February 2017 and 30 April 2019 in two indications resulting from CLTI, namely chronic ulceration or recent minor amputation with delayed healing. Results One-year AFS rate reached 53.6 (-19.8; +16.3)%. One-year overall survival rate reached 67.9 (-20.5; +13.1)%. Main causes of death were infections and related to palliative care implying reduction or withdrawal of regular dialysis treatment. Hypotension episodes were the main rheopheresis adverse events with a prevalence rate of 13.5%. Rheopheresis sessions significantly reduced fibrinogen, C-reactive protein, alpha 2-macroglobulin, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, IgM, and estimated plasma viscosity (P < .0001). Conclusion Rheopheresis may improve clinical outcomes of CLTI in HD patients. The assessment of rheopheresis effectiveness needs to be confirmed by a multicenter randomized controlled trial, such as the ongoing project in France (RHEO-PAD, NCT: 03975946).
Not file

Dates and versions

hal-03777117 , version 1 (14-09-2022)

Identifiers

Cite

Justine Solignac, Stanislas Bataille, Maxime Touzot, Flora Bruner, Dammar Bouchouareb, et al.. Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series. Journal of Clinical Apheresis, 2022, 37 (1), pp.91-99. ⟨10.1002/jca.21955⟩. ⟨hal-03777117⟩
7 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More